| KXP | Name: | (2S)-1-{[(R)-hydroxy{[(1R,2R,3S,4R,5R,6S)-2,3,6-trihydroxy-4,5-bis(phosphonooxy)cyclohexyl]oxy}phosphoryl]oxy}-3-(octadecanoyloxy)propan-2-yl icosa-5,8,11,14-tetraenoate | Formula: | C47 H85 O19 P3 | SMILES: | C(OC(CCCCCCCCCCCCCCCCC)=O)C(COP(=O)(O)OC1C(O)C(C(C(C1O)OP(O)(O)=O)OP(O)(O)=O)O)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC | InChi: | InChI=1S/C47H85O19P3/c1-3-5-7-9-11-13-15-17-19-20-22-24-26-28-30-32-34-36-41(49)63-39(37-61-40(48)35-33-31-29-27-25-23-21-18-16-14-12-10-8-6-4-2)38-62-69(59,60)66-45-42(50)43(51)46(64-67(53,54)55)47(44(45)52)65-68(56,57)58/h11,13,17,19,22,24,28,30,39,42-47,50-52H,3-10,12,14-16,18,20-21,23,25-27,29,31-38H2,1-2H3,(H,59,60)(H2,53,54,55)(H2,56,57,58)/t39-,42+,43-,44-,45+,46+,47+/m0/s1 | Definition date: | 2019-01-23 | Last modified: | 2019-02-15 | Release date: | 2019-02-20 | Identifier: | (2S)-1-{[(R)-hydroxy{[(1R,2R,3S,4R,5R,6S)-2,3,6-trihydroxy-4,5-bis(phosphonooxy)cyclohexyl]oxy}phosphoryl]oxy}-3-(octadecanoyloxy)propan-2-yl icosa-5,8,11,14-tetraenoate |
|
| KXS | Name: | (1R,2S,5R)-N-(4-methoxyphenyl)-5-methyl-2-(propan-2-yl)cyclohexane-1-carboxamide | Formula: | C18 H27 N O2 | SMILES: | c1c(ccc(c1)OC)NC(C2C(CCC(C)C2)C(C)C)=O | InChi: | InChI=1S/C18H27NO2/c1-12(2)16-10-5-13(3)11-17(16)18(20)19-14-6-8-15(21-4)9-7-14/h6-9,12-13,16-17H,5,10-11H2,1-4H3,(H,19,20)/t13-,16+,17-/m1/s1 | Definition date: | 2019-01-23 | Last modified: | 2019-02-15 | Release date: | 2019-02-20 | Identifier: | (1R,2S,5R)-N-(4-methoxyphenyl)-5-methyl-2-(propan-2-yl)cyclohexane-1-carboxamide |
|
| GYZ | Name: | [(~{Z})-[(3~{S},4~{R},5~{S},6~{S})-6-methyl-3,4,5-tris(oxidanyl)oxan-2-ylidene]amino] ~{N}-phenylcarbamate | Formula: | C13 H16 N2 O6 | SMILES: | C[CH]1OC(=NOC(=O)Nc2ccccc2)[CH](O)[CH](O)[CH]1O | InChi: | InChI=1S/C13H16N2O6/c1-7-9(16)10(17)11(18)12(20-7)15-21-13(19)14-8-5-3-2-4-6-8/h2-7,9-11,16-18H,1H3,(H,14,19)/b15-12-/t7-,9+,10+,11-/m0/s1 | Definition date: | 2018-10-24 | Last modified: | 2019-02-15 | Release date: | 2019-02-20 | Identifier: | [(~{Z})-[(3~{S},4~{R},5~{S},6~{S})-6-methyl-3,4,5-tris(oxidanyl)oxan-2-ylidene]amino] ~{N}-phenylcarbamate |
|
| FJQ | Name: | Tioconazole | Formula: | C16 H13 Cl3 N2 O S | SMILES: | Clc1ccc([CH](Cn2ccnc2)OCc3ccsc3Cl)c(Cl)c1 | InChi: | InChI=1S/C16H13Cl3N2OS/c17-12-1-2-13(14(18)7-12)15(8-21-5-4-20-10-21)22-9-11-3-6-23-16(11)19/h1-7,10,15H,8-9H2/t15-/m0/s1 | Definition date: | 2018-07-12 | Last modified: | 2019-02-15 | Release date: | 2019-02-20 | Identifier: | 1-[(2~{R})-2-[(2-chloranylthiophen-3-yl)methoxy]-2-(2,4-dichlorophenyl)ethyl]imidazole |
|
| I1L | Name: | [2-(2~{H}-1,2,3,4-tetrazol-5-yl)ethanoylamino]azanium | Formula: | C3 H7 N6 O | SMILES: | [NH3+]NC(=O)Cc1n[nH]nn1 | InChi: | InChI=1S/C3H6N6O/c4-5-3(10)1-2-6-8-9-7-2/h1,4H2,(H,5,10)(H,6,7,8,9)/p+1 | Definition date: | 2017-10-27 | Last modified: | 2019-02-15 | Release date: | 2019-02-20 | Identifier: | [2-(2~{H}-1,2,3,4-tetrazol-5-yl)ethanoylamino]azanium |
|
| 9G6 | Name: | N-[2-(7-methoxy-4-morpholin-4-yl-quinazolin-6-yl)oxyethyl]-1,3-benzothiazol-2-amine | Formula: | C22 H23 N5 O3 S | SMILES: | COc1cc2ncnc(N3CCOCC3)c2cc1OCCNc4sc5ccccc5n4 | InChi: | InChI=1S/C22H23N5O3S/c1-28-18-13-17-15(21(25-14-24-17)27-7-10-29-11-8-27)12-19(18)30-9-6-23-22-26-16-4-2-3-5-20(16)31-22/h2-5,12-14H,6-11H2,1H3,(H,23,26) | Definition date: | 2018-04-17 | Last modified: | 2019-02-15 | Release date: | 2019-02-20 | Identifier: | ~{N}-[2-(7-methoxy-4-morpholin-4-yl-quinazolin-6-yl)oxyethyl]-1,3-benzothiazol-2-amine |
|
| BWT | Name: | [[4-(2~{H}-1,2,3,4-tetrazol-5-yl)phenyl]carbonylamino]azanium | Formula: | C8 H9 N6 O | SMILES: | [NH3+]NC(=O)c1ccc(cc1)c2n[nH]nn2 | InChi: | InChI=1S/C8H8N6O/c9-10-8(15)6-3-1-5(2-4-6)7-11-13-14-12-7/h1-4H,9H2,(H,10,15)(H,11,12,13,14)/p+1 | Definition date: | 2017-10-27 | Last modified: | 2019-02-15 | Release date: | 2019-02-20 | Identifier: | [[4-(2~{H}-1,2,3,4-tetrazol-5-yl)phenyl]carbonylamino]azanium |
|
| BWZ | Name: | [[3-(2~{H}-1,2,3,4-tetrazol-5-yl)phenyl]carbonylamino]azanium | Formula: | C8 H9 N6 O | SMILES: | [NH3+]NC(=O)c1cccc(c1)c2n[nH]nn2 | InChi: | InChI=1S/C8H8N6O/c9-10-8(15)6-3-1-2-5(4-6)7-11-13-14-12-7/h1-4H,9H2,(H,10,15)(H,11,12,13,14)/p+1 | Definition date: | 2017-10-27 | Last modified: | 2019-02-15 | Release date: | 2019-02-20 | Identifier: | [[3-(2~{H}-1,2,3,4-tetrazol-5-yl)phenyl]carbonylamino]azanium |
|
| BX5 | Name: | [4-(2~{H}-1,2,3,4-tetrazol-5-yl)butanoylamino]azanium | Formula: | C5 H11 N6 O | SMILES: | [NH3+]NC(=O)CCCc1n[nH]nn1 | InChi: | InChI=1S/C5H10N6O/c6-7-5(12)3-1-2-4-8-10-11-9-4/h1-3,6H2,(H,7,12)(H,8,9,10,11)/p+1 | Definition date: | 2017-10-27 | Last modified: | 2019-02-15 | Release date: | 2019-02-20 | Identifier: | [4-(2~{H}-1,2,3,4-tetrazol-5-yl)butanoylamino]azanium |
|
| EBB | Name: | 7,8-dimethyl-2-(pyrimidin-2-ylsulfanylmethyl)-3~{H}-quinazolin-4-one | Formula: | C15 H14 N4 O S | SMILES: | Cc1ccc2C(=O)NC(=Nc2c1C)CSc3ncccn3 | InChi: | InChI=1S/C15H14N4OS/c1-9-4-5-11-13(10(9)2)18-12(19-14(11)20)8-21-15-16-6-3-7-17-15/h3-7H,8H2,1-2H3,(H,18,19,20) | Definition date: | 2018-03-13 | Last modified: | 2019-02-15 | Release date: | 2019-02-20 | Identifier: | 7,8-dimethyl-2-(pyrimidin-2-ylsulfanylmethyl)-3~{H}-quinazolin-4-one |
|
| EE5 | Name: | 4-[(8-methyl-4-oxidanylidene-7-prop-1-ynyl-3~{H}-quinazolin-2-yl)methylsulfanyl]benzoic acid | Formula: | C20 H16 N2 O3 S | SMILES: | CC#Cc1ccc2C(=O)NC(=Nc2c1C)CSc3ccc(cc3)C(O)=O | InChi: | InChI=1S/C20H16N2O3S/c1-3-4-13-7-10-16-18(12(13)2)21-17(22-19(16)23)11-26-15-8-5-14(6-9-15)20(24)25/h5-10H,11H2,1-2H3,(H,24,25)(H,21,22,23) | Definition date: | 2018-03-15 | Last modified: | 2019-02-15 | Release date: | 2019-02-20 | Identifier: | 4-[(8-methyl-4-oxidanylidene-7-prop-1-ynyl-3~{H}-quinazolin-2-yl)methylsulfanyl]benzoic acid |
|
| 6KB | Name: | 4-[(2~{R},3~{R},4~{S},5~{R})-5-[[[[(2~{R},3~{R},4~{R},5~{R})-5-(6-aminopurin-9-yl)-3-oxidanyl-4-phosphonooxy-oxolan-2-yl]methoxy-oxidanyl-phosphoryl]oxy-oxidanyl-phosphoryl]oxymethyl]-3,4-bis(oxidanyl)oxolan-2-yl]oxybutanoic acid | Formula: | C19 H30 N5 O19 P3 | SMILES: | O=C(CCCOC1OC(C(C1O)O)COP(O)(OP(O)(=O)OCC4OC(n3c2c(c(ncn2)N)nc3)C(C4O)OP(O)(=O)O)=O)O | InChi: | InChI=1S/C19H30N5O19P3/c20-16-11-17(22-6-21-16)24(7-23-11)18-15(42-44(30,31)32)13(28)9(40-18)5-39-46(35,36)43-45(33,34)38-4-8-12(27)14(29)19(41-8)37-3-1-2-10(25)26/h6-9,12-15,18-19,27-29H,1-5H2,(H,25,26)(H,33,34)(H,35,36)(H2,20,21,22)(H2,30,31,32)/t8-,9-,12-,13-,14-,15-,18-,19-/m1/s1 | Definition date: | 2016-04-21 | Last modified: | 2019-02-11 | Release date: | 2017-05-03 | Identifier: | 4-{[(2R,3R,4S,5R)-5-({[(R)-{[(R)-{[(2R,3R,4R,5R)-5-(6-amino-9H-purin-9-yl)-3-hydroxy-4-(phosphonooxy)tetrahydrofuran-2-yl]methoxy}(hydroxy)phosphoryl]oxy}(hydroxy)phosphoryl]oxy}methyl)-3,4-dihydroxytetrahydrofuran-2-yl]oxy}butanoic acid (non-preferred name) |
|
| ZOT | Name: | 2-(3-chloranylbenzo[b][1]benzothiepin-5-yl)oxy-N,N-dimethyl-ethanamine | Formula: | C18 H18 Cl N O S | SMILES: | CN(C)CCOC1=Cc2ccccc2Sc3ccc(Cl)cc13 | InChi: | InChI=1S/C18H18ClNOS/c1-20(2)9-10-21-16-11-13-5-3-4-6-17(13)22-18-8-7-14(19)12-15(16)18/h3-8,11-12H,9-10H2,1-2H3 | Definition date: | 2017-08-17 | Last modified: | 2019-02-08 | Release date: | 2019-02-13 | Identifier: | 2-(3-chloranylbenzo[b][1]benzothiepin-5-yl)oxy-~{N},~{N}-dimethyl-ethanamine |
|
| HO7 | Name: | (6S)-6-(4-bromophenyl)-2,3,5,6-tetrahydroimidazo[2,1-b][1,3]thiazole | Formula: | C11 H11 Br N2 S | SMILES: | c3c(C2CN1CCSC1=N2)ccc(c3)Br | InChi: | InChI=1S/C11H11BrN2S/c12-9-3-1-8(2-4-9)10-7-14-5-6-15-11(14)13-10/h1-4,10H,5-7H2/t10-/m1/s1 | Definition date: | 2018-07-16 | Last modified: | 2019-02-08 | Release date: | 2019-02-13 | Identifier: | (6S)-6-(4-bromophenyl)-2,3,5,6-tetrahydroimidazo[2,1-b][1,3]thiazole |
|
| J87 | Name: | N-[2-methoxy-4-(morpholin-4-yl)phenyl]-2-(pyridin-3-yl)-1,3-thiazole-5-carboxamide | Formula: | C20 H20 N4 O3 S | SMILES: | c4(c1cnccc1)ncc(C(Nc2c(cc(cc2)N3CCOCC3)OC)=O)s4 | InChi: | InChI=1S/C20H20N4O3S/c1-26-17-11-15(24-7-9-27-10-8-24)4-5-16(17)23-19(25)18-13-22-20(28-18)14-3-2-6-21-12-14/h2-6,11-13H,7-10H2,1H3,(H,23,25) | Definition date: | 2018-08-22 | Last modified: | 2019-02-08 | Release date: | 2019-02-13 | Identifier: | N-[2-methoxy-4-(morpholin-4-yl)phenyl]-2-(pyridin-3-yl)-1,3-thiazole-5-carboxamide |
|
| KS7 | Name: | 4-[3-(3,5-dimethoxyphenyl)-1,2,4-oxadiazol-5-yl]-1-methyl-9-(2-methylpyridin-4-yl)-1,4,9-triazaspiro[5.5]undecane | Formula: | C25 H32 N6 O3 | SMILES: | COc1cc(cc(c1)OC)c5noc(N2CCN(C4(C2)CCN(c3cc(ncc3)C)CC4)C)n5 | InChi: | InChI=1S/C25H32N6O3/c1-18-13-20(5-8-26-18)30-9-6-25(7-10-30)17-31(12-11-29(25)2)24-27-23(28-34-24)19-14-21(32-3)16-22(15-19)33-4/h5,8,13-16H,6-7,9-12,17H2,1-4H3 | Definition date: | 2019-01-11 | Last modified: | 2019-02-08 | Release date: | 2019-02-13 | Identifier: | 4-[3-(3,5-dimethoxyphenyl)-1,2,4-oxadiazol-5-yl]-1-methyl-9-(2-methylpyridin-4-yl)-1,4,9-triazaspiro[5.5]undecane |
|
| EZ7 | Name: | N-[2-(2-{4-[(R)-(2-methyl-2H-tetrazol-5-yl)(phenyl)methyl]piperazine-1-carbonyl}pyridin-4-yl)-1,3-benzoxazol-5-yl]acetamide | Formula: | C28 H27 N9 O3 | SMILES: | c2c(cc1nc(oc1c2)c3ccnc(c3)C(N4CCN(CC4)C(c5ccccc5)c6nnn(n6)C)=O)NC(C)=O | InChi: | InChI=1S/C28H27N9O3/c1-18(38)30-21-8-9-24-22(17-21)31-27(40-24)20-10-11-29-23(16-20)28(39)37-14-12-36(13-15-37)25(19-6-4-3-5-7-19)26-32-34-35(2)33-26/h3-11,16-17,25H,12-15H2,1-2H3,(H,30,38)/t25-/m1/s1 | Definition date: | 2018-02-14 | Last modified: | 2019-02-08 | Release date: | 2019-02-13 | Identifier: | N-[2-(2-{4-[(R)-(2-methyl-2H-tetrazol-5-yl)(phenyl)methyl]piperazine-1-carbonyl}pyridin-4-yl)-1,3-benzoxazol-5-yl]acetamide |
|
| EUY | Name: | (2R)-N-hydroxy-2-methyl-2-(methylsulfonyl)-4-{2-oxo-4-[4-(2H-1,2,3-triazol-2-yl)phenyl]pyridin-1(2H)-yl}butanamide | Formula: | C19 H21 N5 O5 S | SMILES: | C3(C=C(c1ccc(cc1)n2nccn2)C=CN3CCC(C)(S(C)(=O)=O)C(NO)=O)=O | InChi: | InChI=1S/C19H21N5O5S/c1-19(18(26)22-27,30(2,28)29)8-12-23-11-7-15(13-17(23)25)14-3-5-16(6-4-14)24-20-9-10-21-24/h3-7,9-11,13,27H,8,12H2,1-2H3,(H,22,26)/t19-/m1/s1 | Definition date: | 2018-02-02 | Last modified: | 2019-02-08 | Release date: | 2019-02-13 | Identifier: | (2R)-N-hydroxy-2-methyl-2-(methylsulfonyl)-4-{2-oxo-4-[4-(2H-1,2,3-triazol-2-yl)phenyl]pyridin-1(2H)-yl}butanamide |
|
| K6V | Name: | N-[(2S)-1-hydroxypropan-2-yl]butanamide | Formula: | C7 H15 N O2 | SMILES: | C(C(C)NC(CCC)=O)O | InChi: | InChI=1S/C7H15NO2/c1-3-4-7(10)8-6(2)5-9/h6,9H,3-5H2,1-2H3,(H,8,10)/t6-/m0/s1 | Definition date: | 2018-11-02 | Last modified: | 2019-02-08 | Release date: | 2019-02-13 | Identifier: | N-[(2S)-1-hydroxypropan-2-yl]butanamide |
|
| FNB | Name: | 1-[2-chloranyl-7-[(1~{R},2~{R})-1,2-dimethoxypropyl]pyrazolo[1,5-a]pyrimidin-6-yl]-3-[5-chloranyl-6-(1,2,3-triazol-2-yl)pyridin-3-yl]urea | Formula: | C19 H19 Cl2 N9 O3 | SMILES: | CO[CH](C)[CH](OC)c1n2nc(Cl)cc2ncc1NC(=O)Nc3cnc(n4nccn4)c(Cl)c3 | InChi: | InChI=1S/C19H19Cl2N9O3/c1-10(32-2)17(33-3)16-13(9-22-15-7-14(21)28-29(15)16)27-19(31)26-11-6-12(20)18(23-8-11)30-24-4-5-25-30/h4-10,17H,1-3H3,(H2,26,27,31)/t10-,17+/m1/s1 | Definition date: | 2018-07-20 | Last modified: | 2019-02-08 | Release date: | 2019-02-13 | Identifier: | 1-[2-chloranyl-7-[(1~{R},2~{R})-1,2-dimethoxypropyl]pyrazolo[1,5-a]pyrimidin-6-yl]-3-[5-chloranyl-6-(1,2,3-triazol-2-yl)pyridin-3-yl]urea |
|
| HVD | Name: | (1'R,2'R)-5'-methyl-6-pentyl-2'-(prop-1-en-2-yl)-1',2',3',4'-tetrahydro[1,1'-biphenyl]-2,4-diol | Formula: | C21 H30 O2 | SMILES: | C=1(CCC(C(C=1)c2c(CCCCC)cc(cc2O)O)C(=C)C)C | InChi: | InChI=1S/C21H30O2/c1-5-6-7-8-16-12-17(22)13-20(23)21(16)19-11-15(4)9-10-18(19)14(2)3/h11-13,18-19,22-23H,2,5-10H2,1,3-4H3/t18-,19+/m0/s1 | Definition date: | 2018-07-23 | Last modified: | 2019-02-08 | Release date: | 2019-02-13 | Identifier: | (1'R,2'R)-5'-methyl-6-pentyl-2'-(prop-1-en-2-yl)-1',2',3',4'-tetrahydro[1,1'-biphenyl]-2,4-diol |
|
| HVJ | Name: | (1'R,2'R)-5',6-dimethyl-2'-(prop-1-en-2-yl)-1',2',3',4'-tetrahydro[1,1'-biphenyl]-2,4-diol | Formula: | C17 H22 O2 | SMILES: | c1(C)c(c(O)cc(c1)O)C2C(C(/C)=C)CCC(C)=C2 | InChi: | InChI=1S/C17H22O2/c1-10(2)14-6-5-11(3)7-15(14)17-12(4)8-13(18)9-16(17)19/h7-9,14-15,18-19H,1,5-6H2,2-4H3/t14-,15+/m0/s1 | Definition date: | 2018-07-24 | Last modified: | 2019-02-08 | Release date: | 2019-02-13 | Identifier: | (1'R,2'R)-5',6-dimethyl-2'-(prop-1-en-2-yl)-1',2',3',4'-tetrahydro[1,1'-biphenyl]-2,4-diol |
|
| 9RD | Name: | (cyclohex-1-ene-1,2-diamine)platinum(2+) | Formula: | C6 H12 N2 Pt | SMILES: | [Pt+2]1[nH+]c2c([nH+]1)CCCC2 | InChi: | InChI=1S/C6H12N2.Pt/c7-5-3-1-2-4-6(5)8 | Definition date: | 2017-06-02 | Last modified: | 2019-02-08 | Release date: | 2019-02-13 | Identifier: | (cyclohex-1-ene-1,2-diamine-kappa~2~N,N')platinum(4+) |
|
| 9A6 | Name: | 7-(4-methylpiperazin-1-yl)-N-(5-methyl-1H-pyrazol-3-yl)-2-[(E)-2-phenylethenyl]quinazolin-4-amine | Formula: | C25 H27 N7 | SMILES: | CN1CCN(CC1)c3cc4nc([C@H]=Cc2ccccc2)nc(c4cc3)Nc5cc(nn5)C | InChi: | InChI=1S/C25H27N7/c1-18-16-24(30-29-18)28-25-21-10-9-20(32-14-12-31(2)13-15-32)17-22(21)26-23(27-25)11-8-19-6-4-3-5-7-19/h3-11,16-17H,12-15H2,1-2H3,(H2,26,27,28,29,30)/b11-8+ | Definition date: | 2018-02-13 | Last modified: | 2019-02-08 | Release date: | 2019-02-13 | Identifier: | 7-(4-methylpiperazin-1-yl)-N-(5-methyl-1H-pyrazol-3-yl)-2-[(E)-2-phenylethenyl]quinazolin-4-amine |
|
| JE1 | Name: | 2-[4-(aminomethyl)-4-methylpiperidin-1-yl]-5-{[2-(trifluoromethyl)pyridin-3-yl]sulfanyl}pyrimidin-4(3H)-one | Formula: | C17 H20 F3 N5 O S | SMILES: | C2(C(Sc1c(C(F)(F)F)nccc1)=CN=C(N2)N3CCC(CN)(C)CC3)=O | InChi: | InChI=1S/C17H20F3N5OS/c1-16(10-21)4-7-25(8-5-16)15-23-9-12(14(26)24-15)27-11-3-2-6-22-13(11)17(18,19)20/h2-3,6,9H,4-5,7-8,10,21H2,1H3,(H,23,24,26) | Definition date: | 2018-09-05 | Last modified: | 2019-02-08 | Release date: | 2019-02-13 | Identifier: | 2-[4-(aminomethyl)-4-methylpiperidin-1-yl]-5-{[2-(trifluoromethyl)pyridin-3-yl]sulfanyl}pyrimidin-4(3H)-one |
|